Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access study of everolimus in angiomyolipoma associated with tuberous sclerosis complex
2012-005397-63Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in angiomyolipoma (AML), tuberous sclerosis complex (TSC), sponsored by Novartis. Started Jan 2014; status: completed.
02
Drugs
everolimus
03
Conditions
angiomyolipoma (AML)tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on 2012-005397-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005397-63.